MHRA Issues Class 2 Medicines Recall Drug Alert
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom has issued a drug alert concerning a class 2 medicines recall of paracetamol tablets.
The Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom has issued a drug alert concerning a class 2 medicines recall of paracetamol tablets on June 13, 2019.
The drug recall, which has been instigated by M & A Pharmachem-manufacturer of the paracetamol tablets in question, has been issued as a result of a small number of pots from each batch being found to be discolored due to fungal contamination. In the alert, it is noted that the fungi have been identified as Penicillium citrinium and Penicillium brevicompactum, although it is not thought that any tablets will have made it to patients as the discoloration is noticeable once the pack is opened.
Advice for healthcare professionals and wholesalers is to stop supplying the affected batches immediately and for a quarantine of all remaining stock to be performed so that it can be sent back to the supplier via the approved processes. Action on this alert should be taken within a 48-hour period.
Precise batch numbers of the affected medicines can be found in the official MHRA issued alert.
Source: MHRA
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
